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INTRODUCTION
While many scientific breakthroughs have the potential to
improve the quality of life, such breakthroughs are often
accompanied by significant risk. For over three decades, scientists,
politicians, and concerned citizens have attempted to reconcile the
potential benefits and risks of genetic engineering in general, and the
genetic manipulation of agriculture in particular. This paper begins
by summarizing the main scientific issues and environmental
concerns associated with biotechnology.' While the science behind
biotechnology is highly technical, even a novice can quickly
appreciate the lack of consensus on many of the most fundamental
issues regarding genetically modified organisms (GMOs). This
knowledge enhances understanding of what is at stake and how the
people, organizations, and governments, which have accepted the
responsibility for regulating GMOs, have dealt with these issues.
The paper continues by presenting a detailed analysis of the
Cartagena Protocol. It begins with a brief history of the 6-year
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1. Biotechnology refers to "The use of recombinant DNA or
other specific molecular gene transfer or exchange techniques to add
desirable traits to plants, animals, or other organisms, or to enhance
biological processes. Organisms modified by genetic engineering
are sometimes referred to as transgenic, bioengineered, or
genetically modified." See THE U.S. HOUSE COMMITEE ON
AGRICULTURE GLOSSARY at http://agriculture.house.gov/-
glossary/genetic-engineering.htm (last visited on June 14, 2000).
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negotiation process that, ultimately led to the adoption of the treaty
on January 29, 2000. Finally, this paper discusses three critical
aspects of the treaty in greater detail.
I. WORLD OF GMOs
Part I of this paper begins with a basic introduction to genetic
engineering and biotechnology. In Part II, this paper examines the
potential benefits of biotechnology. Conversely, Part Ill discusses
the risks associated with genetic engineering including major risks to
human health and our natural environment. Finally, Part IV
examines how a new multilateral environmental treaty called the
Cartagena Protocol proposes to deal with these issues.
A. Brief Introduction to Genetically Modified Organisms (GMOs)
A basic understanding of the science and technology behind
GMOs is necessary in order to fully appreciate and intelligently
consider the international regulatory framework that will be imposed
upon them by the Cartagena Protocol. As U.S. Agricultural
Secretary Dan Glickman noted, "[w]e as a society must sort through
some very complex issues to make informed decisions about policy,
programs and initiatives that are in the best interest of all involved-
consumers, farmers, processors, everyone in the food chain."'2 Part I
of this paper is designed to introduce the science and technology
behind genetic engineering and its application to agriculture. Of
particular significance is the importance of genetically modified
organisms to the world's food supply. Furthermore, Part I argues
that because modern biotechnology differs from traditional cross
breeding in several important ways, regulators were justified in
establishing an international protocol to regulate the trade of GMOs.
2. Secretary of Agriculture Dan Glickman, Remarks at the
Advisory Committee on Biotechnology Opening Meeting, (Mar. 29,
2000), at http://www.usinfo.state.gov/topical/global/biotech/-
00032901.htm (last visited Mar. 20, 2001).
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1. Biotech Basics
For many years agronomists 3 have sought to improve the
quality and yield of crops through selective breeding techniques.4
These techniques have been used to enhance the desired
characteristics of crops on a large-scale basis.' However, this
process is both time consuming and imprecise (in so far as it is not
effective in controlling individual traits).6  Since the 1970's,
agrobiologists have looked to biotechnology and genetic engineering
to improve their ability to affect specific traits.7 More specifically,
"[b]iotech procedures allow scientists to move specific genes within
an organism or from one organism to another, whether from an
organism of the same species or from a different species."8 The
result of this process is a bioengineered or "transgenic" crop referred
to as a "Genetically Modified Organism" (GMO) or a "Living
Modified Organism" (LMO). 9
3. See WEBSTER'S THIRD NEW INTERNATIONAL DICTIONARY
44 (3d ed. 1995). (One who studies the science of farm management
and the production of field crops).
4. See generally, RAOUL A. ROBINSON, RETURN. TO
RESISTANCE: BREEDING CROPS TO REDUCE PESTICIDE DEPENDENCE
3-18 (1996).
5. See id.
6. Agricultural Biotechnology: Hearings on H.R. Before the
Subcomm. on Risk Management, Research and Specialty Crops of
the Comm. on Agriculture, 106th Cong. 295-315 (1999).
7. "The use of recombinant DNA or other specific molecular
gene transfer or exchange techniques to add desirable traits to plants,
animals, or other organisms, or to enhance biological processes.
Organisms modified by genetic engineering are sometimes referred
to as transgenic, bioengineered, or genetically modified." See THE
U.S. HOUSE COMM. ON AGRICULTURE GLOSSARY available at
http://agriculture.house.gov/ glossary/genetic.engineering.htm (last
visited on Feb'8, 2000).
8. See Holly Saigo, Agricultural Biotechnology and the
Negotiation of the Biosafety Protocol, 12 GEO. INT'L ENVT'L. L.
REV. 779, 783 (2000).
9. See id.
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Thus, in the broadest sense, the term GMO is used to identify
certain products produced through modem biotechnology. 0 The
Cartagena Protocol itself defines LMO as "any living organism that
possesses a novel combination of genetic material obtained through
the use of modem biotechnology."" This includes the use of in vitro
nucleic acid techniques, including rDNA and "direct injection of
nucleic acid into cells or organelles" or "fusion of cells beyond the
taxonomic family" used to overcome natural physiological
reproductive or recombination barriers. 12
2. Use of Genetically Engineered Crops
Transgenic crops have been planted commercially in the
United States since 1995.13 Since then, their use has risen
dramatically. In 1996, only 8 million acres of genetically engineered
crops were grown in the U.S.' 4 By 1998, 45 million acres of land
were planted with a variety of genetically engineered crops. 15 In
1998, "[o]ver 25 percent of the U.S. corn acreage, 30 percent of
soybean acreage and 45 percent of cotton acreage were planted with
10. U.S. DEP'T OF STATE, FACT SHEET: BIOTECH BASICS
(1999) available at http://www.state.gov/www/global/oes/fs-
biotechbasics_991201.html (last visited Feb. 20, 2001) [hereinafter
BIOTECH BASICS].
11. Cartagena Protocol on Biosafety to the Convention on
Biological Diversity, Jan. 29, 2000, art. 3(g), available at
http://www.untreaty.un.org/English/notpubl/27-8a-eng.htm (last
visited on July 30, 2000) [hereinafter Cartagena Protocol].
12. See id at art. 3(i).
13. See Press Release, National Academies, U.S. Regulatory
Systems need Adjustment as Volume and Mix of Transgenic Plants
Increase in Marketplace (April 5, 2000) available at
http://usinfo.state.gov/topical/biotech/0004050I.htm (last visited on
May 12, 2000).
14. U.S. DEP'T OF AGRIC., Economic Research Service,
Impacts of Adopting Genetically Engineered Crops in the United
States (last updated on Dec. 15, 2000) available at
http://www.ers.usda.gov/Emphases/issues/genengcrops.htm (last
visited on Mar. 26, 2001).
15. See id.
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biotech varieties."' 6 The U.S. Department of State estimates that
worldwide, almost 69 million acres of biotech crops were planted in
1998.17 Last year more than 70 million acres of transgenic crops
were planted in the U.S. alone.' 8 "By 1999 nearly 60 percent of
soybean-harvested acres in the U.S. was planted with herbicide-
resistant soybeans, while nearly 40 percent of corn-harvested
acreage and over 60 percent of cotton-harvested acreage was planted
with biotech varieties." 19 While it appears that these numbers may
have temporarily peaked,2 ° the percentages of genetically engineered
crops represent a substantial portion of the U.S. and worldwide food
supply.
3. The Need for a New Multinational Environmental Agreement
Unfortunately, there is little consensus within the scientific
community with regards to GMOs.2' Even today, 30 years after the
first genes were spliced and 10 years after GMO products first
appeared on our supermarket shelves, scientists have yet to reach a
16. See BIOTECH BASICS, supra note 10, available at
http://www.state.gov/www/global/oes/fsbiotechbasics_991201.html
17. See id.
18. See id.
19. William W. Lin, William Chambers, & Joy Harwood,
Biotechnology: U.S. Grain Handlers Look Ahead, AGRICULTURAL
OUTLOOK, April 2000 available at http://usda.mannlib.cornell.edu-
/reports/erssor/economics/ao-bb/2000/ao270.asc.
20. A nationwide market survey of GM seed sales conducted
by Worldwatch, an environmental watchdog, suggests that global
acreage of GM crops could fall as much as 25 percent compared to
1999. See generally, Julian Borger, US farmers' desert GM crops,
THE GUARDIAN, February 17, 2000.
21. See ORGANIZATION FOR ECONOMIC COOPERATION AND
DEVELOPMENT (OECD), THE OECD EDINBURGH CONFERENCE ON
THE SCIENTIFIC AND HEALTH ASPECTS OF GENETICALLY MODIFIED
FOODS, EDINBURGH, SCOTLAND, Feb. 18-Mar. 1 2000: GM Food
Safety: Facts, Uncertainties, and Assessment, RAPPORTEUR'S
SUMMARY (March 1, 2000) available at http://www.oecd.org/-
subject/biotech/edinburgh.htm (last visited on Feb 8, 2001)
[hereinafter OECD].
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consensus on whether genetically engineered crops are
fundamentally different from traditional cross-bred or selectively
bred crops.2" The vitality of this debate was reaffirmed at the recent
OECD Edinburgh Conference on the Scientific and Health Aspects
of Genetically Modified Foods.23 According to the OECD
Rapporteur's Summary, while some scientists see genetic
modification merely as an extension of traditional breeding
techniques, others see genetic modification as a drastic change in
crop production.24
If genetic engineering is simply a variety of breeding then we
may not be justified in treating genetically engineered foods
differently then non-genetically engineered foods. Professor Chua
Nam-Hai, Chairman of the Institute of Molecular Agrobiology,
believes that genetic modification is simply a way to fast forward
convention breeding.25 Thus, it did not come as a great shock to
many scientists when, in 1992 the FDA concluded that genetically
engineered foods did not present any novel risks and that as a result,
it was not necessary to implement more restrictive regulatory
controls over them. More recently, over twenty four hundred
prominent scientists, including two Nobel Prize laureates (James
Watson and Norman Bourlaug),26 signed a declaration in support of
agricultural biotechnology which states that "[t]he addition of new or
different genes into an organism by recombinant DNA techniques
22. Id.
23. The OECD conference drew together 400 participants
from 25 countries. John Krebs of Oxford University chaired the
conference. Id.
24. See generally, id.
25. Lea Wee, Get a vaccine from a banana?, THE STRAIGHTS
TIMES (Singapore), August 29, 1999, 1999 WL 8260913, at *1.
26. See Press Release, AgBio World, Noble Prize Winners
Endorse Agricultural Biotechnology (Feb 7, 2000) available at
http://www.agbioworld.com/pr/watson/html (last visited Feb 8,
2001) (Watson, along with colleague Crick, earned a Nobel Prize in
Medicine in 1962 for his work in discovering of the structure of
DNA; Borlaug was awarded a Nobel Peace Prize in 1970 for his
work developing hybrid wheat to increase food production in Third
World countries).
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does not inherently pose new or heightened risks relative to the
modification of organisms by more traditional methods....
Yet, often time's GMO advocates, including the biotech
industry and the U.S. government, downplay or altogether ignore
what some consider to be fundamental differences between organic
crops and GMOs.28 According to Dr. Michael Antoniou, a senior
lecturer in molecular pathology at Guy's Hospital in the U.K.,
"[f]rom the standpoint of the fundamental principles of genetics and
the limitations in the technology, GE is neither more precise nor a
natural extension of traditional cross breeding methods. If anything
the opposite would appear to be true.",29 Philip Regal, a professor of
ecology at the University of Minnesota-St. Paul, argues that the
biotech industry and the U.S. government simply fails to take into
consideration several fundamental differences between rDNA
30
27. See Petition from C.S. Prakash, Prof., Tuskegee
University, to Scientific Comm., AgBio World, Scientists In Support
of Agricultural Biotechnology available at
http://www.agbioworld.com/petition/phtml (last visited on Feb 8,
2001) (emphasis added).
28. For instance, in response to a question about the
difference between biotech and traditional plant breeding techniques,
the U.S. Department of State simply noted the centuries long
practice of intermingling genes through crossbreeding and then
segued into biotech's ability to add speed and predictability to this
process, thereby reinforcing the notion that biotech only differs from
cross-breeding in its effectiveness. See generally, BIOTECH BASICS,
supra note 9, at. http://www.state.gov/www/global/oes/fs-
biotechbasics_991201.html.
29. Dr. Michael Antoniou, GENETIC ENGINEERING AND
TRADITIONAL BREEDING METHODS: A TECHNICAL PROSPECTIVE
(1995).
30. rDNA refers to recombinant deoxyribonucleic acid.
Recombinant DNA techniques create DNA formed by combining
segments of DNA from different organisms. See generally,
Economic Research Service, U.S. DEP'T OF AGRIC., Genetically
Engineered Crops: Agricultural Biotechnical Concepts and
Definitions available at http://ers.usda.gov/Emphases/Harmony/
issues/genencrops/terms.htm (last visited on Mar. 8, 2000).
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techniques and conventional breeding. 31 For instance, using rDNA
techniques can form radically new combinations of competitive
features by "leap-frogging" adaptive traits over "vast phylogenetic
distances., 32 Additionally, only with rDNA can exchange-based
trade-offs associated with the exchange of alleles (variants of genes)
be circumvented.33  Furthermore, unlike traditional breeding
practices, rDNA has the potential to "reprogram the large fraction of
genomes that are functionally homozygous." 34 And finally, a host
organism's failure to recognize transgenes can result in unusual
genetic side effects.35 While Professor Regal insists that experts in
the field no longer use these "generic safety" arguments, they are
still circulated by non-technical scientists and used by biotech public
relations persons.
36
The FDA has taken the position that GMOs are similar to
traditionally cross bred crops, and as a result, do not need to be
labeled or otherwise subject to stricter regulation. 37 Recently, U.S.
public interest attorney Steven Drunker revealed that, as early as
March 18, 1992, scientists at the FDA recognized major differences
between genetic engineering and traditional crop breeding.38 For
instance, FDA microbiologist Dr. Louis Pribyl concluded that,
"[t]here is a profound difference between the types of unexpected
31. See Philip Regal, A Brief History of Biotechnology Risk
Debates and Policies in the United States, in EDMONDS INSTITUTE
OCCASIONAL PAPER available at http://www.edmonds-
institute.org/regal.html (last visited on Feb. 20, 2001) [hereinafter
Regal].
32. Id.
33. See id.
34. Id.
135. See id.
36. See Regal, supra note 30.
37. See Kristi Coale, Mutant Food (last visited on April 24,
2001) http://www.salon.com/news/feature/2000/01/12/food/index.-
html.
38. See Press Release, Soil Association, US Public Interest
Attorney Uncovers Suppressed Evidence of Potential GM Food
Health Risks (Feb. 28, 2000) available at
http://www.soilassociation.org/SA/SaWebDoc.nsf/($All)!)OpenVie
w (last visited on Apr. 5, 2001).
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effects from traditional breeding and genetic engineering. '" 39
Additionally, according to the Soil Association, in January of 1992,
"[t]he head of the Biological and Organic Chemistry Section chided
agency bureaucrats for turning prior policy 'on its head' in
attempting to equate bioengineered foods with their conventional
counterparts. ' '40 These opinions raise important questions about the
credibility of the FDAs long standing position on GMOs.
The views of these scientists are meant to illustrate both the
highly technical nature of the GMO debate and the intellectual
vulnerability of non-experts attempting to regulate GMOs on an
international basis. As U.S. Secretary of Agriculture Dan Glickman
recently noted in a speech given at the 1" Meeting of the Standing
Committee on Biotechnology Food and Fiber Production and the
Environment at the National Academy of Sciences, "[i]t's clear from
the intense public debate we've all seen over the last year or two,
that there is no consensus on biotechnology. 4 1 While the verdict is
still out on whether genetically engineered crops are fundamentally
different from those harvested from traditional cross breeding
techniques, it appears that a vocal minority of scientists have
successfully raised enough credible evidence to justify a separate
regulatory device to control the flow of GMO products in
international trade.
II. THE BENEFITS OF GMOs
For years, scientists, governments, and private industry have
touted the enormous benefits of GMOs. Such benefits include the
potential to reduce pesticide and herbicide use, to reduce pressures
on rain forests, to improve both the quantity and quality of the global
food supply by reducing hunger and improving nutritional content,
to distribute vaccines, to enhance agricultural productivity, and to
39. Id.
40. Id.
41. Secretary of Agriculture Dan Glickman, Remarks at the
Agricultural Biotechnology Initiative, (May 4, 2000), available at
http://usinfo.state.gov/topical/global/biotech/00050401 .htm (last
visited on Feb 12, 2001).
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reduce prices for consumers. 42 However, as British Prime Minister
Tony Blair recently emphasized, "[t]he key word here is potential,
both in terms of harm and benefit. The potential for good highlights
why we are right not to slam the door on GM food or crops without
further research. The potential for harm shows why we are right to
proceed very cautiously indeed.",43 This section will attempt to
discuss some of the potential and proven benefits of GMOs. An
understanding of these benefits is necessary to appreciate the
positions taken by several of the negotiating groups, in particular the
Miami group, at the First Extraordinary Meeting of the Conference
of the Parties to the Convention on Biological Diversity and later at
the Resumed Session for the Adoption of the Protocol on Biosafety.
This part of the paper begins by examining the effects that
biotechnology can have on environmental conservation. The paper
continues by emphasizing the amazing degree to which scientists can
enhance the nutritional quality of particular crops. Finally, this part
of the paper deals with the delicate matter of feeding the worlds
ever-growing population.
1. Environmental Conservation
GMO advocates argue that advances in modem
biotechnology can be used to slow environmental degradation and
foster sustainable development. The biggest improvement may
come from a decrease in the need for pesticides and herbicides to
control pests and weeds." According to the National Academy of
Sciences,
[t]he attraction of herbicide-tolerant crops for farmers
is that it lets them control weeds more efficiently and
cheaply. Freed to use a single, effective spray without
42. See Regal, supra note 30, available at
http://www.edmonds-institute.org/regal.html.
43. Tony Blair, The key to GM is its potential, both for harm
and good, available at http:///www.independent.co.uk/news/-
UK/2000-02/blair270200.shtml (Feb. 27, 2000) (last visited on Feb.
8, 2001) (emphasis added).
44. See Eric S. Grace, BIOTECHNOLOGY UNZIPPED, PROMISES
AND REALITIES 105-121 (1997). [hereinafter Grace].
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harming their crops, they need fewer application of
herbicide. This saves time in the fields, lowers the
costs of fuel and chemicals, and reduces the farmers'
exposure to herbicides. In addition, less herbicide use
means less environmental damage.45
Additionally, since the 1980's farmers have been using
Bacillus thuringiensis (Bt), a bacterium that, when ingested by
insects, germinates and produces toxins eventually killing the insects
in their own life cycle.46 Scientists have discovered the genetic code
for over 50 Bt insecticides and the chemical is used against gypsy
moth caterpillars, tobacco hornworms, Colorado potato beetles and
cotton bollworms. 4 7 According to the National Agricultural Statistics
Service, "two million fewer pounds of insecticide were used in 1998
to control bollworm and budworm than were used in 1995, before Bt
insect protected cotton was introduced. 4 8 Similarly, scientists are
working on ways to modify genes to boost bacterial efficiency,
thereby decreasing the need for fertilizers.49
Additionally, "[b]iotechnology could provide enhanced
resistance to natural climactic variation and lessen reliance on water
source management. Plants could be made to withstand, for
instance, a drop in temperature and frost by modifying their
production of linoleic acid. '' 50 Canadian researchers "estimate that
grape production in southern Ontario could double by developing
grape varieties able to withstand freezing temperatures 2°C lower
than the minimum endured by current vines.' Scientists are also
working on new strains of crops that can thrive in marginal lands
45. Id. at 107.
46. See id. at 116.
47. See id. at 117.
48. See Environmental Safety: Regulations and Benefits
available at http://www.whybiotech.com/9_2_c.html (last visited on
May 15, 2000).
49. See id.
50. See BIOTECH BASICS, supra note 9, available at
http://www.state.gov/www/global/oes/fsbiotechbasics_991201. html
(last visited Feb. 20, 2001).
51. See Grace, supra note 43, at 122.
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currently fallow due to iron, salt, or acid content.52  These
developments could decrease pressure on other natural resources
such as tropical rainforests. Finally, biotechnology could reduce the
need for tillage, "which causes both soil and water runoff and soil
nutrient depletion" by increasing the lands ability to support
continuous farming.
53
2. Increasing Nutritional Content
Genetic engineering represents an incredible opportunity to
alter the nutritional quality of plants. 54 One of the best examples
comes from a study performed by Ingo Potrykus and published
recently in the prestigious journal Science. According to demagogic
studies, "one-quarter of the world's people are dependent on rice as a
primary staple. Of those, 400 million are deficient in vitamin A.",
55
The U.N. estimates that over 2 million children die each year from
severe vitamin A deficiency. 56 Using genetic engineering, Ingo
Potrykus has been able to create a variety of rice called "golden rice"
52. Id. at 123; see also See BIOTECH BASICS, supra note 9,
available at http://www.state.gov/www/global/oes/fs-
biotechbasics_991201.html (last visited Feb. 20, 2001).
53. See BIOTECH BASICS, supra note 9, available at
http://www.state.gov/www/global/oes/fsbiotechbasics_991201.html
(last visited Feb. 20, 2001).
54. See Genetically Modified Crops Benefit Agricultural
Sector, Public, Sen. Lugar Says, DAILY ENVIRONMENT, Jan. 25,
2000, at A-8. ISSN 1521-9402.
55. Chris Sumerville, The Genetic Engineering of Plants, in
BIOTECHNOLOGY: THE SCIENCE AND THE IMPACT, at 12, (Conference
held on Jan. 2000), available at http://www.usemb.nl bioproc; see
also U.S. Ambassador Schneider, Remarks on Biotechnology and
Europe: Promise and Paradox (Mar. 22, 2000), available at
http://usinfo.state.gov/ topical/ global/biotech/00040301.htm (last
visited on Feb. 8, 2001).
56. See Guy Gugliotta, Gene-Altered Rice May Help Fight
Vitamin A Deficiency Globally, WASH. POST, January 14, 2000, at
A7 [hereinafter Gugliotta]; People who suffer from vitamin A
deficiency may suffer sever vision impairment, including blindness,
and are more susceptible to other diseases. See id. at A6.
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that will provide the necessary Beta Carotene to meet the people's
daily requirements. The new "golden rice" contains three
transplanted genes that allow plants to produce rice kernels carrying
beta-carotene, a compound that is converted to vitamin-A within the
human body.57 Plans are already under way to distribute this new
variety of rice to subsistence farmers within 3 years and at no cost.58
According to GMO proponents, "golden rice" is just the tip
of the iceberg. The U.S. Department of State reports that crops can
be modified to reduce saturated fat content in cooking oils
(particularly those made form corn, soybean, and canola), and that
potatoes are being modified to absorb less fat when frying.59
"Nutriceuticals are being developed, including fruits and vegetables
containing higher levels of certain nutrients such as Vitamins C and
E, and beta-carotene, to help reduce the risk of chronic diseases such
as some cancers and heart disease. Rice is being produced with an
improved protein to include higher levels of the essential amino acid,
lysine." 60 In Singapore, reports have circulated that scientists are
modifying soybeans to contain more genistein, a compound that has
anti-cancer effects.61 Amazingly enough the lab that brought us
golden rice is also working on another strain of rice with increased
iron content.62 While many of the advances in nutritional content are
still in the research phase, the potential to improve the lives of
billions of people through modern biotechnology is truly awesome.
3. Increasing Worldwide Food Supply
The human population on the Earth is growing at an
astonishing rate. At the start of the last century, the Earth's
57. Id.
58. See id.
59. See BIOTECH BASICS, supra note 19, available at
http://www.state.gov/www/global/oes/fsbiotechbasics_991201.html
(last visited Feb. 20, 2001).
60. See id.
61. See Lea Wee, supra note 24, at * 1.
62. Iron deficiency-anemia is the world's worst nutritional
disorder, affecting over 2 billion people worldwide. See Gugliotta,
supra note 54, at A6.
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population was a mere 1.65 billion. 63 Today, the population is
estimated at over 6 billion.64 At this rate, we can expect to add
roughly 800 million new mouths to feed every ten years.65 Some
researchers estimate that the world population may reach 8 billion by
2025.66 For example, the population in Sub-Sahara is expected to
double by 2025, while "nothing in the regions agricultural history
suggests it will increase food output to meet the demographically
driven expansion of demand. 67
The prospect of feeding an ever-growing population is often
portrayed as an impossible task.68 "Today roughly half the world's
crop land is devoted to growing cereals. If we combine their direct
intake (e.g. as cooked rice or bread) with their indirect consumption
(about 40% of all grain is currently fed to livestock) then cereals
account for approximately two-thirds of all human calorie intake. 69
World population growth has outpaced cereal production every year
since 1984.70 "Between 1950 and 1984, world grain output rose an
astonishing 260 percent .... While we are responsible to feed
approximately 90 million new mouths every year, "land degradation,
63. See UNITED NATION, The World at Six Billion, Tbl. 1
(World Population, year 0 to near stabilization) (ESW/P/WP.154),
Oct. 12, 1999.
64. See id.
65. Tim Dyson, World Food Trends and Prospects to 2025,
96 PROC. NAT'L ACAD. SCI. 5929, 5932 (1999) [hereinafter Dyson].
66. See id. at 5933-34. See also BIOTECH BASICS, supra note
9, available at http://www.state. gov/www/global/oes/fs-
biotechbasics_991201.html (stating he U.S. State Department
estimates the world's population may reach 10 billion by 2030).
67. See Dyson, supra note 66, at 5934.
68. See generally, David Brower, Forward to PAUL EHRLICH,
THE POPULATION BOMB, at xiii (1975).
69. See Dyson, supra note 66, at 5929.
70. Id. This may be a cause for some alarm considering that
cereal production outpaced population growth almost every year
from 1951-1984. See id. See also David Hoisington et al., Plant
Genetic Resources: What can they contribute towards increased
crop productivity?, 96 PROC. NAT'L ACAD. So. 5937, 5937 (May
1999) [hereinafter Hoisington].
71. See Grace, supra note 45, at 110
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pest resistance, pollution, and climate change have slowed or leveled
growth in crop production.,
72
While the results of the Green Revolution 73 were spectacular,
the stark reality is that biotechnology may be the only way to
increase crop yields to meet the world's ever growing population.
7 4
Due, in a large part, adoption of high yielding rice and wheat
production technology, Asian cereal production has increased more
than three times during the period between 1961 and 1998.75 Nobel
Laureate and father of the Green Revolution, Norman E. Borlaug,
believes that from here on in "[iut is access to new technology that
will be the salvation of the poor . .'.,76 "Production in Asia, where
more than 90 percent of the world's rice is consumed grew by 116
percent between 1966 and 1997"" 7 "Between 1950 and 1984, world
grain output rose an astonishing 260 percent.,
78
Despite these advances, the U.S. Department of State
estimates that biotechnology will "increase crop yields by 20% for
smallholder farmers profitably without degrading natural
resources." 79 According to Borlaug, the "IRRI remains optimistic
that it will be successful in developing new 'super rice,' with
fewer-but highly-productive-tillers. While still probably 10 years
away from widespread impact on farmers' fields, IRRI claims that
this new plant type, in association with direct seeding, could increase
rice yield potential by 20-25 percent."
80
72. Id. at 110.
73. A movement to breed new, high yield stains of basic
grains for individual habitats in developing worlds.
74. See Grace, supra note 45, at 110.
75. Norman E. Borlaug and Christopher Dowswell, Global
Food Security: Harnessing Science in the 21st Century (March 7,
2000) available at http://www.useu.be/ISSUES/borlaug0807.html
(last visited on Feb. 20, 2001).
76. See id.
77. See Gugliotta, supra note 57, at A-7.
78. See Grace, supra note 45, at 110.
79. See BIOTECH BASICS, supra note 9, available at
http://www.state.gov/www/global/oes/fsbiotechbasics_991201.html
(last visited Feb. 20, 2001).
80. See Borlaug, supra note 73, available at
http://www.useu.be/ISSUES/borlaug0807.htm-.
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III. THE RISKS OF GMOs
While the potential benefits of biotechnology appear
81 82
staggering, a vocal minority of scientists, consumer advocates,
and environmental groups 83 has raised serious questions concerning
the potential risks associated with genetic engineering. 84 However,
recent reports from the OECD Conference and the National
Academy of Sciences suggest that more long-term studies must be
conducted before we can be certain about the risks GMOs present to
the natural environment.8 ' The Cartagena Protocol reflects this
concern in its adoption of the Precautionary Approach, which allows
States to deny the importation of GMOs without conclusive
scientific evidence that such products are actually harmful to humans
or the environment.86 This portion of the paper focuses on potential
harms to human health and examines possible threats to biodiversity.
81. See e.g. World Scientists' Statement, Institute of Science
in Society, Open Letter from World Scientists to All Governments
concerning Genetically Modified Organisms (GMOs) (Jan. 9, 2000)
available at http://www.i-sis.org/list.shtml (last visited on Feb. 8,
2001) (calling for immediate suspension of a environmental releases
of GM crops-signed by 386 scientists from 51 countries) [hereinafter
World Scientists'].
82. See, e.g., BioDemocracy and Organic Consumers
Association available at http://www.purefood.org./ (last visited on
Feb. 8, 2001).
83. See, e.g., GREENPEACE available at http://www.-
greenpeace.org/-geneng/ (last visited on Feb. 8, 2000).
84. See, e.g., World Scientist, supra note 79, available at
http://www.isis.org/lists.html.
85. See OECD, supra note 20, available at http://www.-
oecd.org/subject/biotech/edinburgh.htm.
86. See United Nations, Cartagena Protocol on Biosafety to
the Convention on Biological Diversity (2000), art. 10(6)-11(8),
http://untreaty.un.org?English?notpubl/27-8a-eng.htm (supporting
that the precautionary principle is used) [hereinafter Cartagena].
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1. Harm to Human Health
While the Cartagena Protocol does not specifically cover
threats to human health, a brief summary of these threats is
necessary to fully appreciate the current policy debate. Potential
threats to human health cover a wide range of topics including
human allergens, antibiotic resistance, and the production of new
toxins.87 Many consumers fear that genetically engineered crops will
introduce new food allergens that people would not know to avoid. 8
"A study by scientists at the University of Nebraska shows that
soybeans genetically engineered to contain Brazil-nut proteins cause
reaction in individuals allergic to Brazil nuts."89 According to that
study, "[a]n allergen from a food known to be allergenic can be
transferred into another food by genetic engineering." 90 In the New
England Journal of Medicine, Marion Nestle, Ph.D, M.P.H. at New
York University argued that
[m]ore information about incidence, prevalence,
dietary exposure, antigeniticity, immune responses,
diagnosis, and treatment would help researchers,
regulators and biotechnology companies predict
whether transgenic proteins are likely to cause harm.
In the special case of transgenic soybeans, the donor
87. U.S. STATE DEPARTMENT, FACT SHEET: THE CARTAGENA
PROTOCOL BIOSAFETY (2000), available at
http://www.state.gov/www/global/ors/fscart-protbiosaf_000216.ht
ml (last visited on Mar. 1, 2000) [hereinafter CARTAGENA FACT
SHEET].
88. UNION OF CONCERNED SCIENTISTS: FACT SHEET: RISKS
OF GENETIC ENGINEERING (2000) available at
http://www.ucsusa.org/agriculture/gen.risks.html (last visited on
Mar. 6, 2001). [hereinafter RISKS OF GENETIC ENGINEERING 2].
89. Id.
90. Julie A. Nordlee et al., Abstract, Identification of a
Brazilian-Nut Allergen in Transgenic Soybeans, Article Abstract,
334 NEW ENG. J. MED. 688, 688 (1996) available at
http://www.nejm.org/content/1996/0334/0011/0688.asp (last visited
on Feb 12, 2001).
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species was known to be allergenic... [t]he next case
could be less ideal, and the public less fortunate. 91
However, a new report transmitted to the Committee on
Science for the 10 6 th Congress found that risks of introducing new
allergens into the food supply are the same for both biotech and
traditionally breeding varieties.92 Thus, while scientists remain
uncertain about the affects of genetic engineering on the spread of
allergens, it appears that some consumers (particularly those with
known allergies) may have a legitimate cause for concern.
According to The Union of Concerned Scientists, "genetic
engineering often uses genes for antibiotic resistance as 'selective
markers.' 93 While most of these genes have no additional use,
some are still expressed in plant tissues.94 The presence of antibiotic
resistance genes poses two potential risks to human health. First,
eating foods with such genes could "reduce the effectiveness of
antibiotics to fight disease when these antibiotics are taken with
meals." 95 For instance if a tomato containing antibiotic resistance
genes was eaten at the same time as an antibiotic, it could potentially
destroy the antibiotic in the stomach. 96 Second, antibiotic-resistance
genes could be transferred to human or animal pathogens, thereby
making them impervious to antibiotics. 97 While transference of
genetic materials from plants to bacteria is extremely unlikely, the
mere possibility may raise some cause for concern. The report to the
91. Marion Nestle, Allergies to Transgenic Foods-
Questions of Policy, 334 N. ENGL. J. MED. 726, 727 (1996).
92. CHAIRMAN NICK SMITH ON THE SUBCOMMITTEE ON BASIC
RESEARCH, 106TH CONG., SEEDS OF OPPORTUNITY: AN ASSESSMENT
OF THE BENEFITS, SAFETY, AND OVERSIGHT OF PLANT GENOMICS
AND AGRICULTURAL BIOTECHNOLOGY 106-B, Appendix 1, page 79
(Comm. Print 2000) [hereinafter CHAIRMAN NICK SMITH].
93. NION OF CONCERNED SCIENTISTS: FACT SHEET: RISKS OF
GENETIC ENGINEERING (2000) available at
http://www.ucsusa.org/agriculture/gen.risks.html (last visited on
Feb. 8, 2001) [hereinafter RISKS OF GENETIC ENGINEERING 1].
94. See id.
95. Id.
96. See id.
97. See id.
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Committee on Science concluded that "[t]he risk that a health hazard
will be created through the use of antibiotic resistance markers in the
development of new plant varieties using agricultural biotechnology
is insignificant.
'
"
98
Other potential threats to human health include increasing
toxicity within plants resulting from the reactivation of inactive
pathways, contamination of food with high levels of toxic metals,
such as mercury, from soil fertilized with municipal sludge, and an
increase in fungal toxins, such as aflatoxin, resulting from the
removal of genes necessary to protect plants against fungi. 99
2. Harm to the Environment
One major ecological risk associated with transgenic crops is
the flow of genes to non-target species through outcropping or cross-
pollination. While outcropping occurs naturally, new evidence
suggests that genes from transgenic plants may be as much as 20
times more likely to infect relative species than their natural
counterparts. 100 According to Joy Bergelson, assistant professor of
ecology and evolution at the University of Chicago, "genetic
engineering can substantially increase the incidence of outcropping
in selfing species."'' 1 One possibility is that the new traits might
confer on wild or weedy relatives of crop plants the ability to thrive
in unwanted places. 10 2 Similarly, evidence suggests that gene flow
can occur from plant to plant, from plant to bacteria, 'and from plant
98. See CHAIRMAN NICK SMITH, supra note 90, at 79.
99. See id. at 79-80
100. See J Bergelson et al., Promiscuity in Transgenic
Plants, 395 NATURE 25, 25 (1998).
101. See UNIVERSITY OF CHICAGO MEDICAL CENTER,
Promiscuous Plants May Spread Genes to Weeds available at
http://www.sciencedaily.com/releases/1998/09/980903090806.htm
(last visited on Mar. 6, 2001).
102. See generally, id.
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to virus, 0 3 with the most significant threat coming from the flow of
herbicide-tolerant genes from a plant to a close relative. 10
4
"Recent reports indicate that the use of herbicide resistant
products represents more than 50 percent of the GE crops today."'
10 5
Some scientists and environmentalists are concerned that "[p]lants
engineered to be herbicide resistant could become so evasive they
are a weed problem themselves, or they could spread themselves to
wild weeds making them more evasive."' 0 6 These super-weeds have
the potential of creating an imbalance in natural ecosystems resulting
in the displacement of both native flora and fauna. °7 In 1998,
scientists at Iowa State University reported that "velvetleaf,
smartweed, and waterhemp species of weeds had developed
tolerance or resistance to glyphosate (Roundup).' 0 8  Additionally,
103. See generally, Thomas R. Mikkelsen et al., The Risk of
Transgene Spread, 380 NATURE 31, 31 (1996).
104. See, e.g., Rikke Jorgensen and Bente Anderson,
Spontaneous Hybridization Between Oilseed Rape (Brassica Napus)
and Weedy B. campestris (Brassicaceae): A Risk of Growing
Genetically Engineered Modified Oilseed Rape, 81 AMER. J.
BOTANY 1620, 1620-26 (1995).
105. PHYSICIANS AND SCIENTISTS FOR RESPONSIBLE
APPLICATION OF SCIENCE AND TECHNOLOGY (PSRAST), Traits
Introduced in food by Genetic Engineering available at
http://www.psrast. org/geprodct.htm, at * 1-2 (last visited on April 1,
2000). According to the Union of Concerned Scientists, "[i]n 1998
herbicide-resistant crops were planted on nearly 50 million acres,
about 71 percent of the total while Bt insect resistant crops were
planted on 19 million acres or 28 percent." See UNION OF
CONCERNED SCIENTISTS, A Surge in Commercial Transgenic Crops,
THE GENE EXCHANGE (1998) available at
http://www.ucsusa.org/Gene/w98.world.html (last visited on Feb 8,
2001)
106. See GREENPEACE, The End of the World as We Know
It: The Environmental Costs of Genetic Engineering available at
http://www.greenpeace.org/-commss/cbio/brief2.html (last visited
on Mar. 30, 2001).
107. See id.
108. See WORLD WILDLIFE FUND, Do Genetically-
Engineered (GE) crops reduce pesticides? The Emerging Evidence
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genetically engineered crops "will increase the resistance of pests to
both pesticides and the novel gene in the crop itself, requiring
additional, and potentially more toxic, sprays than the ones the
technology is supposed to help reduce." 109
Environmentalists fear that farmers will respond to super-
weeds and super-pests by increasing their applications of pesticides
and herbicides "which will lead to even greater resistance pressures
or use of other, more toxic, herbicides."' 10  Additionally, pest
resistance to Bt due to the proliferation of Bt crops will eventually
render the Bt spray useless. This in unfortunate considering that
when used in moderation, Bt is relatively benign. The World
Wildlife Fund ("WWF') predicts that "[e]ven with an effective
refugia and high-dose Bt expression strategy, Bt crops may only be
effective for 10 years maximum. If the refugia strategy fails, which
says "Not Likely" available at http://www.global-reality.com/
biotech/ ARTICLES/newsl32.htm, at *6 [hereinafter WORLD
WILDLIFE FUND]; see also Bob Hartzeler, Are Roundup Ready
Weeds in Your Future, IOWA STATE WEED So. REP. (1998)
available at http://www.weeds.iastate.edu/mgmt/qtr98-
4/roundupfuture.htm, at *1 (last visited on Mar 19, 2001).
109. See WORLD WILDLIFE FUND, supra note 106, at *6.
110. Id. The United States Department of Agriculture that
indicated that "In 1997, increases in adoption of herbicide-tolerant
cotton are estimated to have increased yields, leading to increased
variable profits. However, no statistically significant change on
herbicide use on cotton was observed in 1997." U.S. DEP'T OF
AGRICULTURE, Impacts of Adopting Genetically Engineered Crops
in the U.S. available at
http://www.ers.usda.gov/emphases/harmony/issues/genengcrops/gen
engcrops.htm at *2. Independent research conducted by Dr. Charles
Benbrook shows that based on soybean varietal trials, farmers use
two to five times more herbicides than those planting conventional
soybean varieties, and 10 times more herbicides than farmers who
practice Integrated Weed Management. See Charles Benbrook,
Evidence of the Magnitude and Consequences of the Roundup Ready
yield drag from University-based Varietal Trials in 1998, AgBiotech
InfoNet Technical Paper #1, at 2 (July 13, 1999).
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is likely, the efficacy of Bt sprays could be lost in as little as five
years." 1 
1
Finally, both environmentalists and scientists alike have
expressed concern that transgenic crops may threaten beneficial
insects resulting in an increase in the use of herbicides and an overall
loss of biodiversity. 1 2  "Such beneficial insects include the
lacewings and ladybird beetle."" 3 Scientists from the Swiss Federal
Research Station for Agroecology and Agriculture found that the
mortality rate of lacewig larvae increased significantly after eating
Bt-toxin similar to that found in GE corn produced by Novartis." 4
Researchers also revealed that "[m]ore than 60% of lacewings fed
Bt-corn-reared-corn borers died compared to fewer than 40% of the
control group."'1 5 Scientists at the Scottish Crop Research Institute
found that "ladybird beetles (called ladybugs in the United States)
fed aphids reared on transgenic potatoes experienced reproductive
problems and failed to live as long as ladybirds fed on aphids from
ordinary potatoes (the control group)."'"16  Finally, last year
researchers in the United States showed that monarch butterfly
larvae are at risk of increased mortality from feeding off the pollen
of Bt maize.' 17 "The study published in Nature [the Losey Letter]
found that exposure to pollen from transgenic corn plants expressing
Bacillus thuringiesis endotoxin from a Bt- 11 hybrid (N4640-Bt corn)
111. See WORLD WILDLIFE FUND, supra note 106, at *5.
112. See PHYSICIANS AND SCIENTISTS FOR RESPONSIBLE
APPLICATION OF SCIENCE AND TECHNOLOGY (PSRAST), Genetically
Engineered Crops May Threaten Beneficial Insects (1998) available
at http://www.prast.org/ (last visited on Mar. 8, 2001).
113. Id.
114. See id.
115. Id.
116. Id.; see also UNION OF CONCERNED SCIENTIST, Risk
Research: Transgenic Insect-Resistant Crops Harm Beneficial
Insects (1998) available at http://www.ucsusa.org/Gene/su.risk.html
(last visited on Feb. 20, 2001) (citing A. Hilbeck et. al., Effects of
Trangenic Bacillus thuringiesis Corn-Fed Prey on Martality and
Development Time of Immature Chrysoperla carnea (Neuroptera:
Chrysopidae), ENVT'N ENTOMOLOGY 27 at 480-87 (1998).
117. See J.E. Losey, Transgenic Pollen Harms Monarch
Larvae, 339 NATURE 214, 214 (1999).
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resulted in increased mortality and delayed development compared
with ingestion of non-Bt pollen"" 8 However, Nick Smith, Chairman
of the Subcommittee on Basic Research for the second session of the
106th Congress of the United States found that "[t]he threat posed by
pest -resistant crop varieties developed using agricultural
biotechnology to the Monarch butterfly and other non-target species
has been vastly overblown and is probably insignificant." ' 19 The
findings were buttressed by the fact that the Losey letter120 was
simply a preliminary study that "offered little new information and
was likely to have little relevance to wild Monarch populations in
the field."' 2'  Thus, while many environmentalist groups may have
exaggerated the potential risks associated with agricultural
biotechnology, more long-term studies should be done to establish
with greater certainty what effects this new technology actually has
on non-target and beneficial species.
IV. THE CARTAGENA PROTOCOL ON BIOSAFETY TO THE CONVENTION
ON BIOLOGICAL DIVERSITY
A. The Negotiation of the Cartagena Protocol
1. The 1992 UN Convention on Biological Diversity
"The Convention on Biological Diversity (CBD), negotiated
under the auspices of the United Nations Environment Programme
(UNEP), was adopted on 22 May 1992 and entered into force on 29
118. CANADIAN FOOD INSPECTION AGENCY, Preliminary
Report on the Ecological Impact of BT Corn Pollen on the Monarch
Butterfly in Ontario (2000) available at http://www.cfia-acia.agr.
ca/english/plaveg/pbo/btmone.shtml (last visited on Feb. 20, 2001).
119. See CHAiRMAN NICK SMITH, supra note 90, at 79.
120. T he study was rejected for publication as a research
article in both Nature and Science before being published in the
letters section of Nature. See id. at 44.
121. Id. at 45.
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December 1993."1' 22 As of January 31, 2000, there were 176 parties
to the convention. 123
The CBD recognizes that genetically engineered organisms,
referred to as LMOs may have adverse effects on the sustainability
and conservation of natural resources.124 Article 19 (3) of the CBD
mandates:
[t]he parties shall consider the need for and modalities of a
protocol setting out appropriate procedures, including, in
particular, advanced informed agreement, in the field of the
safe transfer, handling and use of any living modified
organism resulting from biotechnology that may have
adverse effect on the conservation and sustainable use of
biological diversity.1
25
At the 2 nd Conference of the Parties to the Convention on Biological
Diversity, the participating governments decided that a negotiating
process should begin in order to develop a Biosafety Protocol.126
Between July 1996 and February 1999, experts met on six different
occasions to in-order to prepare the protocol text to be adopted by
the Parties to the CBD.'27 In August of 1998, the experts decided
that an Extraordinary Conference of the Parties would be held to
122. INTERNATIONAL INSTITUTE FOR SUSTAINABLE
DEVELOPMENT (IISD), A Brief History of the Biosafety Protocol, 9
EARTH NEGOTIATIONS BULLETIN 1, 1 (2000).
123. Seeid.
124. See generally, Convention of Biological Diversity,
June 5, 1992 [hereinafter Convention of Biological Diversity].
125. Id. at art. 19 (3).
126. UNITED NATIONS ENVIRONMENTAL PROGRAMME
(UNEP), REPORT OF THE SECOND MEETING OF THE CONFERENCE OF
PARTIES TO THE CONVENTION ON BIOLOGICAL DIVERSITY, Rules 3 &
4, UN Doc No. UNEP/CBD/COP/2/19 (1995).
127. See GREENPEACE, The Negotiation of the Biosafety
Protocol available at
http://www.greenpeace.org/~geneng/reports/bio/intrbio2.htm (last
visited on Feb. 12, 2001).
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adopt the Protocol. 128  At that meeting the representative from
Columbia extended an invitation to host the Sixth Meeting of the
Open-ended Ad Hoc Working Group on Biosafety and the
Extraordinary session of the Conference of the Parties to adopt the
Protocol in Columbia in February of 1999.129
2. The Extraordinary Conference of the Parties (ExCOP)
The sixth meeting was supposed to have concluded on
February 19, 1999 with the final protocol to be voted for adoption by
the Parties to the convention three .days later.' 30 Despite the best
efforts of Mr. Veit Koester,' 3 1 Juan Mayr Maldonado,1 32 and over
600 participating representatives from 138 governments, the Parties
could not reach a consensus on a number of important issues. 13
Areas of contention included trade issues, treatment of commodities
and World Trade Order agreements. 134 Articles 4 and 5 of the Draft
Protocol were particularly contentious. Article 4 was intended to
deal with the scope of the protocol, while Article 5 dealt with the
application of the advanced informed agreement (AIA) procedure. 135
128. See UNITED NATIONS ENVIRONMENTAL PROGRAMME
(UNEP), REPORT OF THE FIFTH MEETING OF THE AD Hoc OPEN-
ENDED GROUP OF EXPERTS ON BIOSAFETY, Decision 1115,
U.N.Doc.UNEP/CBD/BSWG/5/3 (1998).
129. Id. at 2.
130. See generally, UNITED NATIONS ENVIRONMENTAL
PROGRAMME (UNEP), REPORT OF THE SIXTH MEETING OF THE AD
Hoc OPEN-ENDED GROUP OF EXPERTS ON BIOSAFETY, Decision 11/5,
UN Doc UNEP/CBD/ExCOP/1/2 (1999) [hereinafter SIXTH
MEETING].
131. Mr. Veit Koester (Denmark) was the Chair of the
Open-ended Ad Hoc Working Group. Id.
132. Mr. Maldonado (Colombian Environment Minister)
chaired the ExCOP. Id.
133. See Belgian Biosafety Server, Biosafety Under the
Biodiversity Convention: A Brief History, Earth Negotiations
Bulletin available at http://biosafety.ihe.be/Biodiv/History.html (last
visited on Feb. 12, 2001).
134. See id.
135. See SIXTH MEETING, supra note 128, at 20-21.
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With respect to Article 4, several negotiating blocks were reluctant
to exclude pharmaceuticals and LMOs destined for contained use;
direct use as food or feed, or for processing (FFPs) from the
protocol. 136 With respect to Article 5, many argued, "a seed is a
seed" and were determined to see that all seeds were included in the
AIA procedure.1 37 While not a party to the CBD, the United States
exerted considerable influence over the scope of the protocol.1 38
Many, viewed the United States' effort to limit the effect of the
protocol as blatant protectionism for the U.S. biotechnology
industry.139 As a result of these and other problems, the Parties were
unable to finalize the protocol in Cartagena and the Parties agreed to
suspend negotiations. 4 ° As one delegate pointed out, "[i]t is better
to have a stronger Protocol in the future than to settle for an
unsatisfactory solution and a weak Protocol."''
3. The Negotiating Blocks
The 135 countries that participated in the negotiation of the
Cartagena Protocol divided themselves into 5 different negotiating
groups.'42 The countries in each group were generally aligned by the
similar positions they had on the major issues being discussed
hereunder. 143
136. See id.
137. See Chee Yoke Ling, Delayed, but better, Biosafety
Protocol available at http://www.twnside.org.sg/title/delay.htm at * 1
(last visited on Feb. 12, 2001).
138. See Andrew Pollack, With U.S. Under Pressure,
Biotechnology Talks Resume, THE N.Y. TIMES, January 23, 2000.
139. See id. (discussing the resentment toward the U.S.).
140. See id.
141. See Ling, supra note 135, at *1.
142. See GREENPEACE, Country Positions in the Biosafety
Protocol Negotiations available at
http://www.greenpeace.org/-geneng/reports/bio/intrbio8.htm at *1
(last visited on Feb 12, 2001).
143. See id.
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a. The "Like Minded Group"
The Like Minded Group (the "LMG") consisted of "all
developing countries (known as the Group of 77 plus China), but
with exception of Argentina, Chile, and Uruguay." 1" This block
represented the largest number of countries at 75 (or 100 if you
count the members of the Central and Eastern European block) and
almost 80% of the world's population.145 In the broadest sense, this
group was in favor of a strong Biosafety Protocol.'46 Their proposal
required countries exporting commodities, including bulk
commodities such as corn and cotton, to notify importing countries
and seek consent before any shipment was allowed into the
importing countries. 4 7 The LMG was also particularly concerned
about the capacity of developing nations to adequately regulate and
handle GMOs. 4 8 Additionally, the LMG was in favor of
comprehensive identification and documentation requirements, a
strong statement of the precautionary principle, and tough liability
and redress provisions. 149
b. The "Miami Group"
The Miami Group was comprised of 6 counties (the smallest
number) including Canada, Australia, Argentina, Uruguay, Chile and
the US. 5° This group consisted of the largest grain commodity and
144. Id.
145. See id.
146. See id.
147. See U.S. DEP'T OF STATE, Foreign Press Center
Briefing Transcript, Upcoming Biosafety Protocol Negotiations,
Montreal Canada (2000) available at http://www.fpc.gov/00_trans/
sandOlOO.htm (last visited at Feb. 20, 2001).
148. See id.
149. See Aaron Cosbey & Stas Burgiel, The Cartagena
Protocol on Biosafety: An Analysis of Results, INT'L INSTITUTE FOR
SUSTAINABLE DEv., (2000) [hereinafter Cosbey].
150. See Cartagena Biosafety Protocol: New International
Agreement Regulating GMOs available at
http://www.harmonizationalert.org/January00/protocol.htm, at * 1
(last visited on July 20, 2000).
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GMO exporting countries.151 Generally speaking the Miami group
was in favor of a less restrictive Protocol (i.e. one that would not
disrupt international trade in GMOs).152 The main goal of the Miami
Group was to negotiate a treaty that would protect the Earth's
biological resources without disrupting worldwide trade.'53 The
Miami Group argued that commodities, which total 90% of all
GMOs, and pharmaceuticals, should be entirely excluded from the
Protocol or at least from the AIA procedures.'54 The group also
argued for a "savings clause" that could ensure that the Protocol
would not displace or trump any other international agreements (i.e.
the WTO).'55
c. The European Union
The European Union (EU) negotiating block included all 15
members of the EU.'56 The EU attempted to take the middle ground
during the negotiating session.'57 Due in part to the incredible public
outrage over food safety, the EU sought a comprehensive treaty that
would include threats to human health.'58 The EU argued that FFPs
should be included in the treaty even if they were not subject to the
151. See generally, id.
152. See generally, Summary of the Cartagena Protocol on
Biosafety (2000) available at
http://www.greenpeacecanada.org/e/feature-geconsumer/archives/bp
summary.html (last visited on July 20, 2000).
153. See Press Statement from Frank E. Loy, Under
Secretary of State and Global Affairs and Head of the US
Delegation, Upon Adoption of the Biosafety Protocol (Jan. 29, 2000)
available at http://www.state.gov/www/policyremarks/-
2000/000129_loy-biosafety.html (last visited on Feb. 20, 2001).
154. See Who Wants What at the International Biosafety
Protocol Negotiations? available at
http://www.foe.org/safefood/biosafetyneeds.html (last visited on
March 8, 2001) [hereinafter Who Wants What].
155. See id.
156. See Greenpeace, supra note 155.
157. See id.
158. See id.
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AIA procedures." 9 However, the most important issue for the EU
was the inclusion of the precautionary principle into the AIA
procedures. 6 ° Finally, the EU objected to the inclusion of a savings
clause arguing that it could create problems for importing Parties
that denied importation based on the precautionary principle.' 6
d. The "Compromise Group" and the "Central and Eastern European
Group"
Two smaller negotiating groups helped round out the negotiating
sessions. The Compromise Group included Switzerland, Korea,
Mexico, Norway, New Zealand, and possibly Japan.'62 This group
claimed to be acting as a facilitator or mediator and attempted to
broker a compromise in Vienna for a weaker AIA procedure (which
was rejected by the Miami Group).'63 The Central and Eastern
European Group "essentially acted with the Like Minded Group."'" 6
4. A Compromise is Reached
After a break of nearly 11 months from the February meeting in
1999, the Parties reconvened in Montreal, Canada at the Resumed
Session of the First Extraordinary Meeting of the Conference of the
Parties to the Convention on Biological Diversity.'65 Over 700
delegates attended the meeting from governments,
intergovernmental organizations and NGOs, including over 40
159. See generally Who Wants What, supra note 167.
160. See generally GREENPEACE, The Precautionary
Principle and the Biosafety Protocol available at
http://www.greenpeace.org/-geneng/reports/bio/intrbio5.htm (last
visited on May 25, 2001).
161. See generally Who Wants What, supra note 167,
available at http://www.foe.org/safefood/ biosafetyneeds.html.
162. See id.
163. See id.
164. See id.
165. See Cartagena Protocol on Biosafety: Background
available at http://www.biodiv. org/biosafety (last visited on May 25,
2001).
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ministers. 166  After a last minute compromise on the provision
regarding documentation, the Parties to the CBD reached an
agreement in the early hours of Saturday, January 29, 2000.167 The
Protocol was opened for signature from May 15-26, 2000 at the Fifth
Conference of the Parties to the CBD in Nairobi and from June 5,
2000 to June 4, 2001 in New York. 168 Sixty-four governments plus
the European Community signed the Protocol in Nairobi. 169 As of
May 25, 2001 there were ninety six signatories and three parties to
the Cartagena Protocol. 70
The Protocol was immediately hailed as a success. Margrot
Wallstrom, the European Commissioner for the Environment said,
"[t]his is a historical moment and a breakthrough for international
agreements on trade . ,,.71 Wallstrom added that the protocol
"reflects the common will to protect the world's environment and
confirms the importance of the Convention on Biodiversity. ' 172
David Sandalow, Assistant U.S. Secretary of State for Oceans,
Environment and Science commented that "[o]n balance, we think
this is an agreement that protects the environment.' ' 173 "Frank E.
Loy, an undersecretary of state and head of the U.S. team in
166. See id.
167. See Andrew Pollack, 130 Nations Agree on Safety
Rules for Biotech Food, N.Y. TIMES, January 30, 2000.
168. See Decision EM-I/3: Adoption of the Cartagena
Protocol and Interim Agreements available at
http://www.biodiv.org/decisions/default.asp?lg=0&m=excop01 &d=0
3 (last visited on May 25, 2001).
169. See Parties to the Convention on Biological Diversity!
Cartagena Protocol on Biosafety available at
http://www.biodiv.org/world/parties.asp (last visited on May 25,
2001).
170. See id.
171. See EU welcomes international bio-safety trade pact,
REUTERS (Jan 29, 2000) available at
http://home.intekom.com/tminfo/rwOO130.htm, at * 17-18.
172. See id.
173. Id.
174. See Doug Palmer, Countries Reach Landmark GMO
Food Agreement, REUTERS (January 29, 2000) available at
http://home.intekom.com/tminfo/rwOO130.htm, at *17-18.
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Montreal, described the agreement as 'not perfect'. . .however, that
laying out rules will 'make it easier for all of us to harness the
promise of this technology to feed the world's growing
population.... Notwithstanding Under Secretary Loy's remarks,
both environmental groups and biotech industrialists applauded the
Protocol. 75 Michael Khoo a Greenpeace organizer who rallied at
the Montreal Convention said that "[w]e (Greenpeace) won almost
all the points we were pushing for."' 176 The L.A. Times reported that
"[t]he Global Industry Coalition, representing 2,200 biotech
companies, said it too was encouraged by the outcome." 177  If
nothing else, the protocol may be remembered as the first major
international treaty of 21 century that treated an environmental
issue as important as a trade issue. From this standpoint, it is easy to
appreciate why environmental ministers from each of the negotiating
blocks and the environmental NGOs, despite their often intense
differences during the past 5 years, were equally quick to embrace
the new treaty as a success.
B. The Cartagena Protocol
This portion of the paper sets forth the major issues reflected
in the Protocol. It examines the scope of the Protocol, discusses the
Precautionary Principle, and considers the relationship between the
Protocol and other international agreements, particularly the World
Trade Organization (WTO).
1. Scope
As adopted, the Protocol is limited in scope to the to the
transboundary movement of all LMOs that may adversely affect
175. John Burgess, Trade Rules Set on Food Genetics,
Compromise Gained On Labeling Issue, WASH. POST, January 30,
2000, at A20.
176. See Maggie Farley, Deal Struck to Regulate
Genetically Altered Food, L. A. TIMES, January 30, 2000 (last
visited on February 1, 2000) at http://www.latimes.com /news/
nation/20000130/t000009630.html.
176. Id.
177. Id.
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biological diversity.'78 The Protocol does not address food safety
issues or pharmaceuticals.' 79 By the time the Parties arrived at
Montreal, the last major issue under contention was whether to
include LMOs intended for direct use as food, feed, or processing
under the Protocol's Advanced Informed Agreement procedure. 8 °
The Miami Group, and the U.S. in particular, argued that FFPs
should not be included because the costs of regulating such widely
traded commodities, such as corn, wheat, and canola, would be
overly burdensome. 8' Furthermore, they argued that because FFPs
are not intended for introduction in the environment, they do not
possess a real threat to biodiversity. 82 In the end, while FFPs are
covered under the Protocol, they are not subject to the AIA
procedures.
2. The Advance Informed Agreement (AIA) Procedure
The AIA procedures are set forth in Articles 8-10.183 Article 7 of
the Protocol requires the Party of export to comply with Articles 8-
10 prior to the first transboundary movement of LMOs intended for
introduction into the environment of the Party of import.'84 LMOs
intended for direct use as food or feed, or for processing (FFPs) are
specifically excluded from compliance with Articles 8-10.18"
Additionally, Article 7 does not cover the intentional transboundary
178. See Cartagena Protocol, supra note 11, at art. 4.
179. See id. at art. 5.
180. See U.S. DEP'T OF STATE, David B. Sandalow: Press
Briefing at Biosafety Protocol Negotiations, Montreal, Canada (Jan.
25, 2000) available at http://www.state.gov/www/
policy-re.. .000/000125_sandalowbiosafety.html, (last visited on
Feb 20, 2001).
181. See Cosbey, supra note 162, at 3 (2000).
182. See U.S. DEP'T OF STATE, David B. Sandlow: Press
Briefing at U.S. Mission to the European Union, Brussels, Belgium
(January 12, 2000).
183. See Cartagena Protocol, supra note 11, at art. 8-10.
184. See id. at art. 7. Note that article 7 does not apply to
the domestic transit of LMOs.
185. Id.
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movements of LMOs that are unlikely to have an adverse affect on
the conservation or sustainable use of biological diversity (as
determined by the Conference of the Parties).186 Consequently,
while the AIA represents the main regulatory provision contained in
the Protocol it only applies to a small percentage of traded LMOs.'87
Article 8 requires the Party of export to notify, in writing, the
Party of import prior to the first intentional transboundary movement
of all LMOs intended for introduction into the environment.'88 The
notification must include the information contained in Annex 1,
including, inter alia, taxonomic status of both the recipient and
donor organisms, centers of origin and centers of genetic diversity of
the recipient organism, a description of the nucleic acid and the
technique used for the modification introduced, a previous and
existing risk assessment report, and the regulatory status of the LMO
in the State of export.'89 Additionally, the Protocol requires the Party
of export to regulate the accuracy of any disclosures made in
accordance with Annex 1.190
Article 9 requires the Party of import to acknowledge receipt of
the exporting Parties notification within 90 days. 9' The
acknowledgement sent by the importing Party must state whether to
proceed under the domestic regulatory framework of the importing
party or, according to the procedure set froth in Article 10.192 The
Protocol specifically states that a failure of the Party of import to
acknowledge receipt within 90 days does not imply their consent to
an intentional transboundary movement.'93 The importing Party also
has 90 days after receipt of the Article 8 to inform the exporting
Party whether the shipments can proceed only after the Party of
import has given their consent or after no less than 90 days without a
186. Id.
187. See CARTAGENA FACT SHEET, supra note 85, available
at http://www.state.gov/www/global/ors/fscart-prot-biosaf_-.
000216.html.
188. See Cartagena Protocol, supra note 11, at art. 8(1).
189. Id. at annex 1.
190. Id. at art. 8(2).
191. Id. at art. 9(1).
192. Id. at art. 9(2)(c).
193. See Cartagena Protocol, supra note 11, at art. 9(4).
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subsequent written consent. 9 4 If the Party of import chooses to
require the exporting Party to wait for written notification, then the
Party of import has 270 days in which to decide and notify the
Biosafety Clearing-House of its decision.'95 The Protocol states that
a failure to make a decision within 270 does not constitute its
consent to an intentional transboundary movement.'96 The Party of
import can decide to (1) approve the import adding certain
conditions (2) prohibit the import (3) request additional information
or (4) extend the deadline by a definite period of time.'97 Finally,
Article 12 allows the Party of import to review its decision at any
time if new scientific information becomes available.'98
Additionally, the Party of export may request that the Party of import
review a decision it has made under Article 10.199 In such cases, the
Party of import has 90 days to make a decision and set forth its
reasons.
200
LMOs intended for food, feed, or for processing (FFPs) are
covered by Article 11.2°1 Article 11 places the onus on each Party to
enact legislation that restricts the domestic use of FFPs. °2 Parties
have 15 days after making their decisions to inform the other parties
through the Biosafety Clearing-House." 3 Any Party enacting such
legislation must, at a minimum, include the information specified in
Annex II to the Clearing-House. 21 "Thus, while the AIA procedure
lays first responsibility on the Party of export to notify its intent to
export, the procedure for [FFPs] lays first responsibility on potential
importers to develop and announce regulations proactively. ' '20 5
Developing countries in transition that lack a domestic regulatory
framework can take up to 270 days to make a decision regarding the
194. Id. at art. 10(2)(a)-(b).
195. Id. at art. 10(3).
196. Id. at art. 10(7).
197. Id. at art. 10(3)(a)-(d).
198. See Cartagena Protocol, supra note 11, at art. 12(1)
199. Id. at art. 12(2).
200. Id. at art. 12(3).
201. Seeid. at art 11(1)
202. See id.
203. See Cartagena Protocol, supra note 11, at art. 11(1).
204. See id.
205. See COSBEY, supra note 162, at 8.
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first importation of FFPs so long as it undertakes a risk assessment in
accordance with Annex 111.206
3. The Precautionary Principle
Throughout the negotiations, the EU remained steadfast in its
insistence that the precautionary principle be incorporated into the
Protocol. Consequently, the Cartagena Protocol contains the
strongest and most sophisticated expression of the precautionary
principle to date2°7 Both articles 10 (which applies to the direct
release of GMOs into the environment) and 11 (FFPs) state that:
a lack of scientific certainty due to insufficient
relevant scientific information and knowledge
regarding the extent of the potential adverse effects of
a living modified organism on the conservation and
sustainable use of biological diversity in the Party of
import, taking also into account risks to human
health, shall not prevent that Party from taking a
decision, as appropriate, with regards to the import of
the living modified organism in question, as
appropriate, with regard to the import of that living
modified organism... in order to avoid or minimize
such potential adverse effects."'
Additionally, both the Preamble and Article 1 state that the main
objective of the Protocol is to ensure protection against GMOs in
accordance with the "precautionary approach contained in Principle
15 of the Rio Declaration on Environment and Development .... 2 o
The final reference to the Precautionary Principle can be found in
Annex III (Risk Assessment), which states that "[l]ack of scientific
206.See Cartagena Protocol, supra note 11, at art. 11(1).
207. See generally Kristen Dawkins, Battle Royale of the 21st
Century, SEEDLING, March 2000, available at
http://www.grain.org/publications/mar00/mar00l.htm (last visited on
May 25, 2001).
208. Cartagena Protocol, supra note 11, at art. 10(6), art.
11(8).
209. Id. at art. 1.
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knowledge or scientific consensus should not necessarily be
interpreted as indicating a particular level of risk, an absence of risk,
or an acceptable risk. ' 21 °  Clearly, the Cartagena Protocol has
succeeded in propelling the Precautionary Principle to the forefront
of international environmental law.
While a detailed analysis of the Precautionary Principle is beyond
the scope of this paper, the underlying principle behind the
Precautionary Principle can be easily summarized. At the heart of
the Precautionary Principle is the idea that sometimes action must be
taken to prevent human harm or harm to the environment, even in
the face of scientific uncertainty.2 ' According to Frank E. Loy, the
head of the U.S. delegation, the Precautionary Principle stands for
the proposition that "lack of full scientific certainty should not be
used to postpone cost-effective measures to protect the environment
against serious or irreversible threats. 212 According to the European
Commission such action should:
be based on an examination of the potential benefits
and costs of action or lack of action and subject to
review in the light of new scientific data and should
thus be maintained as long as the scientific data
remain incomplete, imprecise or inconclusive and as
long as the risk is considered to high to be imposed
on society. 213
Furthermore, any action taken should be proportionate to the chosen
level of protection, non-discriminatory in its application and
consistent with prior measures." 4  While some Parties were
concerned that the Precautionary Principle would be used as a
210. Id. at annex 111(4).
211. See Nancy Myers, Debating the Precautionary
Principle, available at http://www.sehn.org/ppdebate.html (last
visited on Mar. 20, 2001).
212. Press Briefing by Frank E. Loy and David B. Sandlow,
U.S. Embassy, January 24, 2000.
213. Commission Adopts Communication on Precautionary
Principle, THE EUROPEAN COMMISSION (Feb. 2, 2000), available at
http://europa.eu.int/conin/trade/ whatsnew/ dppen.htm.
214. Id.
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pretense for protectionism (e.g. WTO Beef-Harmones Appellate
Body), the general consensus is that precaution should be part of a
scientific approach, not a substitute for one. However, the Protocol
also contains a provision that allows Parties to take into account
socio-economic considerations in reaching a decision on the import
of GMOs under the Protocol."5 As will be discussed below, it
remains unclear to what extent Parties can base their decisions on the
Precautionary Principle and socio-economic considerations without
violating the provisions of prior international agreements.
4. The Cartagena Protocol and International Law (WTO)
One of the most controversial aspects of the Protocol is the
relationship between the Protocol and other international agreements
(i.e. the WTO). As was discussed earlier, the Miami Group
advocated the inclusion of a "savings clause," while the EU objected
to a savings clause. 16  After lengthy informal negotiations
throughout the Montreal session, the Parties agreed to include three
preambular clauses;
[t]he mutual supportiveness of trade and environment
agreements with a view to achieving sustainable
development; the statement that the Protocol shall not
be interpreted as implying a change in the rights and
obligations of a Party under existing international
agreements and the explanatory statement that the
above clause is not intended to subordinate the
Protocol to other international agreements."7
215. See Cartagena Protocol, supra note 11, at art. 26.
216. See infra Part IV(3)(a)-(b).
217. The Miami Group favored language implying a change
in obligation. The EU argued that the language was not intended to
subordinate Protocol. Report of the Resumed Session of the
Extraordinary Meeting of the Parties for the Adoption of." The
Protocol on Biosafety to the Convention on Biological Diversity,
Colaboraciones, (last visited on July 30, 2000) at
http://www.bioplanet.net/2000febrero/colaboraciones/o22feb2000(1)
.htm.
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Ultimately, the final text does not resolve the question of how the
Protocol related to other international agreements. It appears that
statement that the Protocol will not change any Parties existing
obligations under the WTO and the statement that Protocol will not
be subordinate to those same obligations may come into conflict.
For example, a Party may attempt to implement the Protocol by
banning certain GMOs under Article I I's precautionary principle.218
However, the exporter may still argue that the ban violates the
provisions of the WTOs Agreement on Sanitary and Phytosanitary
Measures (SPS), which requires Parties to establish a scientific basis
for regulation. The wording of the two passages suggests that the
Protocol and the WTO must be read as mutually supportive and not
conflicting. Thus, while the issue remains unresolved, it appears that
the WTO rules would apply to any disputes brought before the
Dispute Settlement Body (DSB). Nonetheless, if the Protocol is
interpreted as creating customary international law, then the DSB or
other international tribunals might rely on the Protocol as a reflection
of the current status of international law (at least with respect to
GMOs).
CONCLUSION
In light of the lack of consensus with respect to the risks
posed by GMOs, the Cartagena Protocol represents a well-balanced
and rational approach to international regulation of genetically
modified organisms. While the Precautionary Principle is not
appropriate for all environmental issues, it is appropriate in this
context. As was discussed in this paper, the potential harm to
biodiversity is staggering. Yet the Protocol does not ban the trade
GMOs. In fact, the Protocol fails to cover 90 percent of GMO goods
(i.e. commodities). Nonetheless, the Protocol has succeeded in
establishing a system to facilitate the sharing of information and
requires the approval of importing Parties for the most dangerous
(potentially) GMOs (i.e. those intended for direct introduction into
the environment). While the Protocol took 6 years to finalize, it
represents only the foundation for greater control over GMO trade in
the future. The Parties have yet to agree on issues of liability,
218. See Cartagena Protocol, supra note 11, at art. 11
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documentation, and identification. For the Protocol to be truly
effective, these controversial issues must be resolved. Yet, as it
stands now, the Protocol is a monument to international negotiation
and a beacon for environmental law. In the end, the greatest
contribution of the Cartagena Protocol will surely be its progeny.

